BlackRock Institutional Trust’s Atara Biotherapeutics ATRA Stock Holding History

BlackRock Institutional Trust’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.19M	Buy	20,255 +195	+1%	+$82.6K	﹤0.01%	2590
2016 Q3	$10.7M	Buy	20,060 +475	+2%	+$258K	﹤0.01%	2298
2016 Q2	$11M	Buy	19,585 +2,895	+17%	+$1.39M	﹤0.01%	2235
2016 Q1	$7.94M	Buy	16,690 +1,074	+7%	+$483K	﹤0.01%	2409
2015 Q4	$10.3M	Buy	15,616 +321	+2%	+$243K	﹤0.01%	2301
2015 Q3	$12M	Buy	15,295 +7,948	+108%	+$9.69M	﹤0.01%	2163
2015 Q2	$9.69M	Buy	7,347 +4,433	+152%	+$5.09M	﹤0.01%	2425
2015 Q1	$3.03M	Buy	2,914 +1,142	+64%	+$755K	﹤0.01%	2940
2014 Q4	$1.19M	Buy	+1,772	New	+$1.08M	﹤0.01%	3299

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Institutional Trust's ATRA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Atara Biotherapeutics (ATRA) stake by 0.97% in Q4 2016, buying an estimated $82.6K and bringing the position to 20,255 shares worth $7.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

BlackRock Institutional Trust first reported a position in ATRA in Q4 2014 and has held it in 9 quarters since. The position peaked at $12M in Q3 2015. 86 funds tracked by Wall St. Rank hold ATRA as of Q4 2016.

BlackRock Institutional Trust held 20,255 shares of Atara Biotherapeutics worth $7.19M as of Q4 2016.
BlackRock Institutional Trust bought 195 Atara Biotherapeutics shares in Q4 2016, an estimated $82.6K.
Atara Biotherapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2590 holding.
BlackRock Institutional Trust first reported a position in Atara Biotherapeutics in Q4 2014 and has held it in 9 quarters since.
BlackRock Institutional Trust's Atara Biotherapeutics position peaked at $12M in Q3 2015.
86 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.